{"id":6830,"date":"2025-04-03T08:24:39","date_gmt":"2025-04-03T06:24:39","guid":{"rendered":"https:\/\/darkgreen-crane-601020.hostingersite.com\/rek-kulmu\/clinical-trials-regulation-ctr\/eu-application-portal-ctis\/"},"modified":"2025-06-25T12:32:11","modified_gmt":"2025-06-25T10:32:11","slug":"eu-application-portal-ctis","status":"publish","type":"page","link":"https:\/\/rekportalen.no\/en\/rek-kulmu\/clinical-trials-regulation-ctr\/eu-application-portal-ctis\/","title":{"rendered":"EU application portal CTIS"},"content":{"rendered":"<p>All applications for approval of drug trials to be conducted in EU\/EEA countries must be applied for via <a href=\"https:\/\/euclinicaltrials.eu\/ctis-for-sponsors\">the EU application portal CTIS<\/a>.<\/p>\n<p>However, if the clinical trial is to be carried out outside CTR&#8217;s geographical scope, approval must be sought from REK via the REK portal; contact the regional REK in the geographical region you belong to if you have questions regarding such studies.<\/p>\n<p>REK KULMU does not offer user support for CTIS; please contact the European Medicines Agency (EMA) for <a href=\"https:\/\/euclinicaltrials.eu\/support-info\">technical support in CTIS.<\/a><\/p>\n<p>For trials that are approved under CTR, CTIS must be used to submit modification applications and adverse events. <\/p>\n<p>A CTR application consists of two parts. Part I consists of the documentation which, in a multinational study, is common to all participating Member States (protocol, questionnaires etc.). Part II contains documentation that is adapted to each individual Member State (Subject information and informed consent in Norwegian, insurance certificate etc.).  <\/p>\n<p>We recommend that applicants familiarise themselves with the document <em>Quick guide for sponsors &#8211; Regulation 536\/2014 in practice<\/em>, which is available on <a href=\"https:\/\/health.ec.europa.eu\/medicinal-products\/eudralex\/eudralex-volume-10_en#set-of-documents-applicable-to-clinical-trials-that-will-be-authorised-under-regulation-eu-no-5362014-once-it-becomes-applicable\">the European Commission&#8217;s website<\/a>. Reference\/resource pages: <\/p>\n<ul>\n<li><a href=\"https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/PDF\/?uri=CELEX:32014R0536&amp;from=EN\">Clinical Trials Regulation 536\/2014. <\/a>Appendix 1 describes what to include in a CTR application <\/li>\n<li><a href=\"https:\/\/ec.europa.eu\/health\/medicinal-products\/eudralex\/eudralex-volume-10_en#set-of-documents-applicable-to-clinical-trials-that-will-be-authorised-under-regulation-eu-no-5362014-once-it-becomes-applicable\">The European Commission&#8217;s website<\/a> for authorized documents, including <u>CTEG&#8217;s<\/u> <em>Questions and Answers document<\/em> and the guidance document for the transition of clinical trials.<\/li>\n<li>Dokumentet <a href=\"https:\/\/health.ec.europa.eu\/system\/files\/2020-11\/harmonisation_guidance_en_0.pdf\">Part II Document Harmonisation Guidance<\/a><\/li>\n<li><a href=\"https:\/\/www.dmp.no\/en\/approval-of-medicines\/clinical-trials\">DMPs webpage<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>All applications for approval of drug trials to be conducted in EU\/EEA countries must be applied for via the EU application portal CTIS. However, if the clinical trial is to be carried out outside CTR&#8217;s geographical scope, approval must be sought from REK via the REK portal; contact the regional REK in the geographical region [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"parent":6353,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_cn_metabox_post_checkbox_dont_send_once":false,"_cn_metabox_post_checkbox_dont_send_ever":false,"inline_featured_image":false,"footnotes":""},"categories":[62],"tags":[],"class_list":["post-6830","page","type-page","status-publish","hentry","category-rek-kulmu-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>EU application portal CTIS - Rekportalen<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/rekportalen.no\/en\/rek-kulmu\/clinical-trials-regulation-ctr\/eu-application-portal-ctis\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EU application portal CTIS - Rekportalen\" \/>\n<meta property=\"og:description\" content=\"All applications for approval of drug trials to be conducted in EU\/EEA countries must be applied for via the EU application portal CTIS. However, if the clinical trial is to be carried out outside CTR&#8217;s geographical scope, approval must be sought from REK via the REK portal; contact the regional REK in the geographical region [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/rekportalen.no\/en\/rek-kulmu\/clinical-trials-regulation-ctr\/eu-application-portal-ctis\/\" \/>\n<meta property=\"og:site_name\" content=\"Rekportalen\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-25T10:32:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/rekportalen.no\/wp-content\/uploads\/2025\/07\/rek.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"573\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/rekportalen.no\\\/en\\\/rek-kulmu\\\/clinical-trials-regulation-ctr\\\/eu-application-portal-ctis\\\/\",\"url\":\"https:\\\/\\\/rekportalen.no\\\/en\\\/rek-kulmu\\\/clinical-trials-regulation-ctr\\\/eu-application-portal-ctis\\\/\",\"name\":\"EU application portal CTIS - Rekportalen\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/rekportalen.no\\\/en\\\/#website\"},\"datePublished\":\"2025-04-03T06:24:39+00:00\",\"dateModified\":\"2025-06-25T10:32:11+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/rekportalen.no\\\/en\\\/rek-kulmu\\\/clinical-trials-regulation-ctr\\\/eu-application-portal-ctis\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/rekportalen.no\\\/en\\\/rek-kulmu\\\/clinical-trials-regulation-ctr\\\/eu-application-portal-ctis\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/rekportalen.no\\\/en\\\/rek-kulmu\\\/clinical-trials-regulation-ctr\\\/eu-application-portal-ctis\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/rekportalen.no\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"REK KULMU\",\"item\":\"https:\\\/\\\/rekportalen.no\\\/en\\\/rek-kulmu\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Clinical Trials Regulation (CTR)\",\"item\":\"https:\\\/\\\/rekportalen.no\\\/en\\\/rek-kulmu\\\/clinical-trials-regulation-ctr\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"EU application portal CTIS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/rekportalen.no\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/rekportalen.no\\\/en\\\/\",\"name\":\"Rekportalen\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/rekportalen.no\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/rekportalen.no\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/rekportalen.no\\\/en\\\/#organization\",\"name\":\"Rekportalen\",\"url\":\"https:\\\/\\\/rekportalen.no\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/rekportalen.no\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/rekportalen.no\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/logo_pms.svg\",\"contentUrl\":\"https:\\\/\\\/rekportalen.no\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/logo_pms.svg\",\"width\":100,\"height\":100,\"caption\":\"Rekportalen\"},\"image\":{\"@id\":\"https:\\\/\\\/rekportalen.no\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EU application portal CTIS - Rekportalen","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/rekportalen.no\/en\/rek-kulmu\/clinical-trials-regulation-ctr\/eu-application-portal-ctis\/","og_locale":"en_US","og_type":"article","og_title":"EU application portal CTIS - Rekportalen","og_description":"All applications for approval of drug trials to be conducted in EU\/EEA countries must be applied for via the EU application portal CTIS. However, if the clinical trial is to be carried out outside CTR&#8217;s geographical scope, approval must be sought from REK via the REK portal; contact the regional REK in the geographical region [&hellip;]","og_url":"https:\/\/rekportalen.no\/en\/rek-kulmu\/clinical-trials-regulation-ctr\/eu-application-portal-ctis\/","og_site_name":"Rekportalen","article_modified_time":"2025-06-25T10:32:11+00:00","og_image":[{"width":1200,"height":573,"url":"https:\/\/rekportalen.no\/wp-content\/uploads\/2025\/07\/rek.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/rekportalen.no\/en\/rek-kulmu\/clinical-trials-regulation-ctr\/eu-application-portal-ctis\/","url":"https:\/\/rekportalen.no\/en\/rek-kulmu\/clinical-trials-regulation-ctr\/eu-application-portal-ctis\/","name":"EU application portal CTIS - Rekportalen","isPartOf":{"@id":"https:\/\/rekportalen.no\/en\/#website"},"datePublished":"2025-04-03T06:24:39+00:00","dateModified":"2025-06-25T10:32:11+00:00","breadcrumb":{"@id":"https:\/\/rekportalen.no\/en\/rek-kulmu\/clinical-trials-regulation-ctr\/eu-application-portal-ctis\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/rekportalen.no\/en\/rek-kulmu\/clinical-trials-regulation-ctr\/eu-application-portal-ctis\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/rekportalen.no\/en\/rek-kulmu\/clinical-trials-regulation-ctr\/eu-application-portal-ctis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/rekportalen.no\/en\/"},{"@type":"ListItem","position":2,"name":"REK KULMU","item":"https:\/\/rekportalen.no\/en\/rek-kulmu\/"},{"@type":"ListItem","position":3,"name":"Clinical Trials Regulation (CTR)","item":"https:\/\/rekportalen.no\/en\/rek-kulmu\/clinical-trials-regulation-ctr\/"},{"@type":"ListItem","position":4,"name":"EU application portal CTIS"}]},{"@type":"WebSite","@id":"https:\/\/rekportalen.no\/en\/#website","url":"https:\/\/rekportalen.no\/en\/","name":"Rekportalen","description":"","publisher":{"@id":"https:\/\/rekportalen.no\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/rekportalen.no\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/rekportalen.no\/en\/#organization","name":"Rekportalen","url":"https:\/\/rekportalen.no\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/rekportalen.no\/en\/#\/schema\/logo\/image\/","url":"https:\/\/rekportalen.no\/wp-content\/uploads\/2025\/01\/logo_pms.svg","contentUrl":"https:\/\/rekportalen.no\/wp-content\/uploads\/2025\/01\/logo_pms.svg","width":100,"height":100,"caption":"Rekportalen"},"image":{"@id":"https:\/\/rekportalen.no\/en\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/rekportalen.no\/en\/wp-json\/wp\/v2\/pages\/6830","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rekportalen.no\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/rekportalen.no\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/rekportalen.no\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/rekportalen.no\/en\/wp-json\/wp\/v2\/comments?post=6830"}],"version-history":[{"count":1,"href":"https:\/\/rekportalen.no\/en\/wp-json\/wp\/v2\/pages\/6830\/revisions"}],"predecessor-version":[{"id":7324,"href":"https:\/\/rekportalen.no\/en\/wp-json\/wp\/v2\/pages\/6830\/revisions\/7324"}],"up":[{"embeddable":true,"href":"https:\/\/rekportalen.no\/en\/wp-json\/wp\/v2\/pages\/6353"}],"wp:attachment":[{"href":"https:\/\/rekportalen.no\/en\/wp-json\/wp\/v2\/media?parent=6830"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rekportalen.no\/en\/wp-json\/wp\/v2\/categories?post=6830"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rekportalen.no\/en\/wp-json\/wp\/v2\/tags?post=6830"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}